FDA to weigh easing limits on unproven peptides promoted by RFK Jr. Peptides and BPC 157 for Pain: PainExam Podcast Apple Podcasts Regulatory Alert: FDA's April 2026 Update on BPC 157 and GHK Cu Holt Law The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Gray Market Peptides: So Much Hype, So Little Data